Xtant Medical Holdings, Inc. Quarterly Depreciation in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Xtant Medical Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q2 2010 to Q2 2024.
  • Xtant Medical Holdings, Inc. Depreciation for the quarter ending June 30, 2024 was $500K, a 25% increase year-over-year.
  • Xtant Medical Holdings, Inc. Depreciation for the twelve months ending June 30, 2024 was $2.2M, a 69.2% increase year-over-year.
  • Xtant Medical Holdings, Inc. annual Depreciation for 2023 was $1.8M, a 50% increase from 2022.
  • Xtant Medical Holdings, Inc. annual Depreciation for 2022 was $1.2M, a 7.69% decline from 2021.
  • Xtant Medical Holdings, Inc. annual Depreciation for 2021 was $1.3M, a 35% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.2M $500K +$100K +25% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.1M $600K +$300K +100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.8M $600K +$400K +200% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.4M $500K +$100K +25% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.3M $400K +$100K +33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.2M $300K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.2M $200K -$100K -33.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.3M $400K +$100K +33.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.2M $300K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $1.2M $300K -$100K -25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.3M $300K -$100K -25% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $1.4M $300K -$200K -40% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.6M $300K -$100K -25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.7M $400K -$300K -42.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2M $400K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 $500K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $400K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $700K -$100K -12.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $800K +$100K +14.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $700K -$210K -23.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $910K +$252K +38.3% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-03-30
Q1 2016 $658K +$493K +298% Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-30
Q1 2015 $165K +$15.2K +10.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q1 2014 $150K -$31.2K -17.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 $181K -$13.3K -6.83% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $195K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q2 2011 $157K +$5.36K +3.53% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-15
Q2 2010 $152K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.